Guest guest Posted November 17, 2002 Report Share Posted November 17, 2002 In a message dated 11/17/2002 11:44:43 PM Pacific Standard Time, FVJAMES writes: > To exclude the possibility of host cells picking up gfp DNA or GFP proteins > leaked from damaged fetal hNSCs, we performed control transplantations > using freeze-thawed hNSCs, which were pre-treated with the same priming > procedure and rAAV-transduction as the experimental groups. We did not > detect any green fluorescent (GFP+) cells in the host tissue in these > control rats for at least ten days after surgery (data not shown). In > animals transplanted with live fetal hNSCs, all nucleated GFP+ cells > originated from the grafted hNSCs as verified by positive labeling with a > monoclonal antibody specifically against human nuclei (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4e</A>), and > negative labeling with a specific antibody against rat cytochrome P450 side > chain cleavage enzyme (P450scc, <A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4f</A>). Therefore, our data indicate that > the GFP+ cells were indeed of human origin, and that host cells were not > labeled by GFP leakage from damaged hNSCs or by spontaneous fusion between > human and rat cells<A HREF= " http://www.nature.com/cgi-taf/DynaPage.taf?file=/neuro/journal/vaop/ncurre\ nt/full/#B28 " >28</A>, <A HREF= " http://www.nature.com/cgi-taf/DynaPage.taf?file=/neuro/journal/vaop/ncurre\ nt/full/#B29 " >29</A>. > > Morphological examination of fetal hNSC grafts showed that GFP+ cells in > the pyramidal cell layer of the CA1 region of the hippocampus acquired > typical pyramidal cell characteristics (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4g</A>). Numerous spines on their > processes indicated a functional maturation of these grafted hNSCs. > Immunocytochemical analyses using the neuron-specific markers NeuN (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4h</A> > ) and TuJ1 (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4i–t</A>) revealed that most GFP+ cells acquire neuronal > labeling 1 month after transplantation into cortex (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4i–k</A>), hippocampus > (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4l–n</A>), medial septum (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4o–q</A>) or spinal cord (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4r–t</A>). Only a > few scattered GFP+ cells were double-labeled with an astrocyte-specific > marker—glial fibrillary acidic protein (GFAP) (data not shown). No GFP+ > cells were immunoreactive to a monoclonal antibody against > galactocerebroside (GalC, data not shown), indicating the absence of > oligodendrocyte differentiation from grafted hNSCs. In addition, negative > staining using an undifferentiated neural stem cell marker, nestin (data > not shown), suggested that all grafted cells had differentiated by one > month after transplantation. > > Unprimed hNSCs become astrocytes in adult rat CNS Although CAG-egfp > transduction did not alter the in vitro differentiation patterns of hNSCs > with or without priming, as previously reported<A HREF= " http://www.nature.com/cgi-taf/DynaPage.taf?file=/neuro/journal/vaop/ncurre\ nt/full/#B26 " >26</A>, it is necessary to > determine whether this is true for these cells grafted in vivo. To exclude > the possibility that GFP expression in fetal hNSCs could be responsible for > the neuronal differentiation observed in vivo, we grafted CAG-egfp-treated > but not FHL-primed hNSCs into spinal cord, cortex, medial septum and > hippocampus (2 104 cells and n = 4 for each region). > > One month after transplantation, stereological analyses showed that > percentages of surviving hNSCs were 11.8 2.0% in cortex, 13.8 3.5% in > medial septum, 16.8 3.2% in hippocampus and 4.8 0.6% in spinal cord. > These survival rates were similar to those of their primed counterparts. > Many of the surviving cells, 61 6.2% in cortex (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F5.html " >F\ ig. 5a</A>), 60.1 4.7% in > medial septum (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F5.html " >F\ ig. 5b</A>), 58.7 3.8 in CA1 of hippocampus (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F5.html " >F\ ig. 5c</A>), 48.9 > 2.3 in dentate gyrus (DG) of hippocampus and 56.9 5.6% in spinal cord (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F5.html " > > Fig. 5d</A>), still expressed nestin one month after transplantation. Neither > neurons nor their GFP+ fibers were detected in the non-neurogenic areas we > examined. However, some grafted hNSCs became TuJ1+ in the neurogenic > dentate gyrus of the hippocampus (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F5.html " >F\ ig. 5e</A>, 11.2 4.8%), which is consistent > with previous observations<A HREF= " http://www.nature.com/cgi-taf/DynaPage.taf?file=/neuro/journal/vaop/ncurre\ nt/full/#B17 " >17</A>. On the other hand, 38.6 8.7%, 39.9 6.0%, > 40.7 3.7%, 39.6 2.9% and 42.7 5.1% of grafted cells became GFAP+ when > they were grafted into cortex, medial septum, CA1, DG and spinal cord (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F5.html " >F\ ig. > 5f</A>), respectively, which is similar to previous reports<A HREF= " http://www.nature.com/cgi-taf/DynaPage.taf?file=/neuro/journal/vaop/ncurre\ nt/full/#B20 " >20</A>. In summary, CAG- > egfp-modified hNSCs without FHL priming remained either undifferentiated or > acquired an astroglial phenotype when grafted into non-neurogenic areas of > the adult rats. Therefore, both in vitro and in vivo data support the > conclusion that the FHL priming procedure, but not CAG-egfp transduction, > is responsible in part for the neuronal differentiation of fetal hNSCs. > > Generation of ChAT+ neurons is region-specific Subtypes of fetal > hNSC-derived neurons in rat CNS were identified by single-channel or merged > confocal xy images with a z-thickness of either 1 m or 0.3 m after > immunofluorescence analyses with various specific antibodies. Many of the > GFP+ neurons were double-labeled with the ChAT-specific antibody in medial > septum (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F6.html " >F\ ig. 6a–c</A>) and spinal cord (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F6.html " >F\ ig. 6d–i</A>) of the host brain, which > are regions containing many endogenous ChAT+ neurons. A few GFP+/ChAT+ > double-labeled neurons were found in prefrontal cortex, an area with a > limited number of endogenous ChAT neurons. We did not find any GFP+/ChAT+ > neurons in the hippocampus, where there are no endogenous ChAT neurons. In > the spinal cord, some transplanted ChAT+ neurons had a size and morphology > that was indistinguishable from endogenous motoneurons (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F6.html " >F\ ig. 6g–i</A>). > Immunohistochemical analyses with antibodies that specifically recognize > other neuronal subtypes also revealed region-specific patterns. For > example, glutamate immunoreactivity was found in the majority of GFP+ cells > grafted into cortex (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F6.html " >F\ ig. 6j–l</A>), some cells in spinal cord and the dentate > gyrus of hippocampus, a few in medial septum, and none in the CA1 region of > hippocampus (data not shown). In contrast, the majority of grafted GFP+ > cells in the CA1 region (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F6.html " >F\ ig. 6m–o</A>) as well as some cells in all other > regions tested (data not shown) were double-labeled with a GABA antibody. > No GFP+ cells were immunoreactive to TH. > > To quantify neuronal differentiation of grafted fetal hNSCs, we counted the > number of GFP+ cell profiles and the number of each phenotype. The vast > majority of surviving GFP+ cells differentiated into neurons, as determined > by TuJ1 staining, including 94.9 1.8% in cortex, 95.4 0.9% in medial > septum, 96.3 1.0% in CA1, 95.1 1.1% in DG and 94.8 1.9% in spinal cord. > In contrast, only small percentages of surviving cells became GFAP+ > astrocytes: 4.4 0.9% in cortex, 3.9 1.1% in medial septum, 3.4 0.7% in > CA1, 4.8 0.7% in DG and 4.4 0.8% in spinal cord. As no significant > differences were observed between FHL-primed and SFHL-primed hNSCs (n = 5 > for each region in each group), ten animals for each region were pooled to > obtain quantitative analyses of neuronal subtypes (ChAT, glutamate or GABA) > with the means ( s.e.m.) (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F7.html " >F\ ig. 7</A>). Specifically, 61.3 5.4% and 55.5 3.2% > of the GFP+ cells become cholinergic neurons when grafted in medial septum > and spinal cord, respectively. Fetal hNSC-derived glutamatergic neurons > were mainly detected in prefrontal cortex (51.1 1.5%) and in a much lower > percentage (13.9 1.7%) in spinal cord. Whereas 71.3 4.9% of GFP+ cells > turned into GABAergic neurons in the CA1 region of hippocampus, smaller > fractions (20–30%) of such neurons were observed in all the other areas > that we transplanted. > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 17, 2002 Report Share Posted November 17, 2002 In a message dated 11/17/2002 11:44:43 PM Pacific Standard Time, FVJAMES writes: > To exclude the possibility of host cells picking up gfp DNA or GFP proteins > leaked from damaged fetal hNSCs, we performed control transplantations > using freeze-thawed hNSCs, which were pre-treated with the same priming > procedure and rAAV-transduction as the experimental groups. We did not > detect any green fluorescent (GFP+) cells in the host tissue in these > control rats for at least ten days after surgery (data not shown). In > animals transplanted with live fetal hNSCs, all nucleated GFP+ cells > originated from the grafted hNSCs as verified by positive labeling with a > monoclonal antibody specifically against human nuclei (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4e</A>), and > negative labeling with a specific antibody against rat cytochrome P450 side > chain cleavage enzyme (P450scc, <A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4f</A>). Therefore, our data indicate that > the GFP+ cells were indeed of human origin, and that host cells were not > labeled by GFP leakage from damaged hNSCs or by spontaneous fusion between > human and rat cells<A HREF= " http://www.nature.com/cgi-taf/DynaPage.taf?file=/neuro/journal/vaop/ncurre\ nt/full/#B28 " >28</A>, <A HREF= " http://www.nature.com/cgi-taf/DynaPage.taf?file=/neuro/journal/vaop/ncurre\ nt/full/#B29 " >29</A>. > > Morphological examination of fetal hNSC grafts showed that GFP+ cells in > the pyramidal cell layer of the CA1 region of the hippocampus acquired > typical pyramidal cell characteristics (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4g</A>). Numerous spines on their > processes indicated a functional maturation of these grafted hNSCs. > Immunocytochemical analyses using the neuron-specific markers NeuN (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4h</A> > ) and TuJ1 (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4i–t</A>) revealed that most GFP+ cells acquire neuronal > labeling 1 month after transplantation into cortex (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4i–k</A>), hippocampus > (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4l–n</A>), medial septum (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4o–q</A>) or spinal cord (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F4.html " >F\ ig. 4r–t</A>). Only a > few scattered GFP+ cells were double-labeled with an astrocyte-specific > marker—glial fibrillary acidic protein (GFAP) (data not shown). No GFP+ > cells were immunoreactive to a monoclonal antibody against > galactocerebroside (GalC, data not shown), indicating the absence of > oligodendrocyte differentiation from grafted hNSCs. In addition, negative > staining using an undifferentiated neural stem cell marker, nestin (data > not shown), suggested that all grafted cells had differentiated by one > month after transplantation. > > Unprimed hNSCs become astrocytes in adult rat CNS Although CAG-egfp > transduction did not alter the in vitro differentiation patterns of hNSCs > with or without priming, as previously reported<A HREF= " http://www.nature.com/cgi-taf/DynaPage.taf?file=/neuro/journal/vaop/ncurre\ nt/full/#B26 " >26</A>, it is necessary to > determine whether this is true for these cells grafted in vivo. To exclude > the possibility that GFP expression in fetal hNSCs could be responsible for > the neuronal differentiation observed in vivo, we grafted CAG-egfp-treated > but not FHL-primed hNSCs into spinal cord, cortex, medial septum and > hippocampus (2 104 cells and n = 4 for each region). > > One month after transplantation, stereological analyses showed that > percentages of surviving hNSCs were 11.8 2.0% in cortex, 13.8 3.5% in > medial septum, 16.8 3.2% in hippocampus and 4.8 0.6% in spinal cord. > These survival rates were similar to those of their primed counterparts. > Many of the surviving cells, 61 6.2% in cortex (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F5.html " >F\ ig. 5a</A>), 60.1 4.7% in > medial septum (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F5.html " >F\ ig. 5b</A>), 58.7 3.8 in CA1 of hippocampus (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F5.html " >F\ ig. 5c</A>), 48.9 > 2.3 in dentate gyrus (DG) of hippocampus and 56.9 5.6% in spinal cord (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F5.html " > > Fig. 5d</A>), still expressed nestin one month after transplantation. Neither > neurons nor their GFP+ fibers were detected in the non-neurogenic areas we > examined. However, some grafted hNSCs became TuJ1+ in the neurogenic > dentate gyrus of the hippocampus (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F5.html " >F\ ig. 5e</A>, 11.2 4.8%), which is consistent > with previous observations<A HREF= " http://www.nature.com/cgi-taf/DynaPage.taf?file=/neuro/journal/vaop/ncurre\ nt/full/#B17 " >17</A>. On the other hand, 38.6 8.7%, 39.9 6.0%, > 40.7 3.7%, 39.6 2.9% and 42.7 5.1% of grafted cells became GFAP+ when > they were grafted into cortex, medial septum, CA1, DG and spinal cord (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F5.html " >F\ ig. > 5f</A>), respectively, which is similar to previous reports<A HREF= " http://www.nature.com/cgi-taf/DynaPage.taf?file=/neuro/journal/vaop/ncurre\ nt/full/#B20 " >20</A>. In summary, CAG- > egfp-modified hNSCs without FHL priming remained either undifferentiated or > acquired an astroglial phenotype when grafted into non-neurogenic areas of > the adult rats. Therefore, both in vitro and in vivo data support the > conclusion that the FHL priming procedure, but not CAG-egfp transduction, > is responsible in part for the neuronal differentiation of fetal hNSCs. > > Generation of ChAT+ neurons is region-specific Subtypes of fetal > hNSC-derived neurons in rat CNS were identified by single-channel or merged > confocal xy images with a z-thickness of either 1 m or 0.3 m after > immunofluorescence analyses with various specific antibodies. Many of the > GFP+ neurons were double-labeled with the ChAT-specific antibody in medial > septum (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F6.html " >F\ ig. 6a–c</A>) and spinal cord (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F6.html " >F\ ig. 6d–i</A>) of the host brain, which > are regions containing many endogenous ChAT+ neurons. A few GFP+/ChAT+ > double-labeled neurons were found in prefrontal cortex, an area with a > limited number of endogenous ChAT neurons. We did not find any GFP+/ChAT+ > neurons in the hippocampus, where there are no endogenous ChAT neurons. In > the spinal cord, some transplanted ChAT+ neurons had a size and morphology > that was indistinguishable from endogenous motoneurons (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F6.html " >F\ ig. 6g–i</A>). > Immunohistochemical analyses with antibodies that specifically recognize > other neuronal subtypes also revealed region-specific patterns. For > example, glutamate immunoreactivity was found in the majority of GFP+ cells > grafted into cortex (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F6.html " >F\ ig. 6j–l</A>), some cells in spinal cord and the dentate > gyrus of hippocampus, a few in medial septum, and none in the CA1 region of > hippocampus (data not shown). In contrast, the majority of grafted GFP+ > cells in the CA1 region (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F6.html " >F\ ig. 6m–o</A>) as well as some cells in all other > regions tested (data not shown) were double-labeled with a GABA antibody. > No GFP+ cells were immunoreactive to TH. > > To quantify neuronal differentiation of grafted fetal hNSCs, we counted the > number of GFP+ cell profiles and the number of each phenotype. The vast > majority of surviving GFP+ cells differentiated into neurons, as determined > by TuJ1 staining, including 94.9 1.8% in cortex, 95.4 0.9% in medial > septum, 96.3 1.0% in CA1, 95.1 1.1% in DG and 94.8 1.9% in spinal cord. > In contrast, only small percentages of surviving cells became GFAP+ > astrocytes: 4.4 0.9% in cortex, 3.9 1.1% in medial septum, 3.4 0.7% in > CA1, 4.8 0.7% in DG and 4.4 0.8% in spinal cord. As no significant > differences were observed between FHL-primed and SFHL-primed hNSCs (n = 5 > for each region in each group), ten animals for each region were pooled to > obtain quantitative analyses of neuronal subtypes (ChAT, glutamate or GABA) > with the means ( s.e.m.) (<A HREF= " http://www.nature.com/neuro/journal/vaop/ncurrent/fig_tab/nn974_F7.html " >F\ ig. 7</A>). Specifically, 61.3 5.4% and 55.5 3.2% > of the GFP+ cells become cholinergic neurons when grafted in medial septum > and spinal cord, respectively. Fetal hNSC-derived glutamatergic neurons > were mainly detected in prefrontal cortex (51.1 1.5%) and in a much lower > percentage (13.9 1.7%) in spinal cord. Whereas 71.3 4.9% of GFP+ cells > turned into GABAergic neurons in the CA1 region of hippocampus, smaller > fractions (20–30%) of such neurons were observed in all the other areas > that we transplanted. > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.